Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides

Area of Science:

• Immunology
• T cell biology
• Transplantation immunology

Background:

• Understanding alloreactive T cell responses is crucial for transplantation success.
• A key question is whether alloreactivity is directed at the allogeneic MHC molecule or the peptides it presents.

Purpose of the Study:

• To determine if alloreactive CD8+ cytotoxic T lymphocytes (CTLs) recognize allogeneic MHC proteins or specific peptides.
• To investigate the nature of epitopes recognized by HLA-A*0201-specific alloreactive CTLs.

Main Methods:

• Development of HLA-A*0201-specific alloreactive human CD8+ CTL lines and clones.
• Acid treatment of target cells to remove epitopes and assess CTL recognition.
• Restoration of recognition using synthetic or extracted peptides and beta-2 microglobulin.
• Peptide extraction, fractionation using reverse-phase HPLC, and assessment of CTL recognition.

Main Results:

• Acid treatment abolished target cell recognition by alloreactive CTLs.
• Synthetic peptides restored antibody binding but not CTL recognition.
• Peptides extracted directly from HLA-A*0201 restored CTL recognition, indicating peptide-specific recognition.
• HPLC fractionation identified distinct peptide peaks recognized by specific CTL clones, confirming complex peptide-MHC recognition.

Conclusions:

• Alloreactive CTLs recognize specific peptides presented by allogeneic HLA-A*0201, not a general MHC conformation.
• Epitopes in allogeneic responses to HLA-A*0201 are complex, involving recognition of multiple unique peptide-MHC complexes.
• These findings have implications for understanding transplant rejection and developing targeted therapies.